Literature DB >> 8600899

Microscopic polyangiitis with ocular involvement.

J C Caster1, D J Shetlar, M A Pappolla, R W Yee.   

Abstract

Microscopic polyangiitis is an exclusively small-vessel (arterioles, capillaries, or venules) vasculitis that primarily involves the kidney and often involves the lungs, skin, or nervous system. Characteristic features include focal segmental glomerulonephritis, nongranulomatous necrotizing vasculitis, and serum positive for perinuclear-staining antineutrophil cytoplasmic antibodies (P-ANCA). We report a case of microscopic polyangiitis with previously unreported eyelid and conjunctival manifestations that responded well to immunosuppressive therapy.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8600899     DOI: 10.1001/archopht.1996.01100130342023

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  3 in total

1.  Clinical characteristics of inflammatory ocular disease in anti-neutrophil cytoplasmic antibody associated vasculitis: a retrospective cohort study.

Authors:  Patompong Ungprasert; Cynthia S Crowson; Rodrigo Cartin-Ceba; James A Garrity; Wendy M Smith; Ulrich Specks; Eric L Matteson; Ashima Makol
Journal:  Rheumatology (Oxford)       Date:  2017-10-01       Impact factor: 7.580

Review 2.  Eye manifestations in patients with perinuclear antineutrophil cytoplasmic antibody-associated vasculitis: case series and literature review.

Authors:  Toshihiko Matsuo
Journal:  Jpn J Ophthalmol       Date:  2007-04-06       Impact factor: 2.447

3.  Acute retrobulbar optic neuritis with anti-myelin oligodendrocyte glycoprotein antibody-associated disease complicated with microscopic polyangiitis: A case report.

Authors:  Tomoyuki Asano; Yuzuka Saito; Naoki Matsuoka; Jumpei Temmoku; Yuya Fujita; Kasumi Hattori; Shunsuke Kobayashi; Akira Ojima; Toshiyuki Takahashi; Haruki Matsumoto; Makiko Yashiro-Furuya; Shuzo Sato; Hiroko Kobayashi; Hiroshi Watanabe; Kiori Yano; Tomomi Sasajima; Kazuo Fujihara; Kiyoshi Migita
Journal:  Medicine (Baltimore)       Date:  2021-04-16       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.